.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,239,173

« Back to Dashboard

Summary for Patent: 6,239,173

Title: 3-phenyl-4-(4(methylsulfonyl)phenyl)-2-(5H)-furanone as a cox-2 inhibitor
Abstract:The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
Inventor(s): Wang; Zhaoyin (Pierrefond, CA), Therien; Michel (Laval, CA)
Assignee: Merck Frosst Canada Inc./Merck Frosst Canada & Co. (Kirkland, CA)
Application Number:09/443,000
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;
Patent Metrics:
Source: PatentQuant.com
Field: Not categorized
Back Citations: 47th percentile
Forward Citations: 0th percentile
Patent PDF download available with subscription

No matches for this query

Premature patent expiration for: 6,239,173

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
6,239,173 May 29, 2013

International Patent Family for Patent: 6,239,173

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria165825<disabled in preview>
Austria212343<disabled in preview>
Australia1269495<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc